DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Sequist LV, Yang JC, Yamamoto N et al.
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

J Clin Oncol 2013;
31: 3327-3334

Download Bibliographical Data

Search in:
Access: